In the study, we present the data on patients with PV, PF, BP, MMP, and OCP who were treated with RTX, intravenous immunoglobulin (IVIG), and conventional immunosuppressive therapy (CIST), and in whom the levels of IgM were followed for long periods of time. This evidence concerns the gene CD40LG and ocular cicatricial pemphigoid.